Release Date: 25/06/14 09:13 Summary: Lapse and Cancellation of Unlisted Options Price Sensitive: No Download Document 55.05KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%